Single-tracer Multiparametric PET Imaging
Part of paid clinical trials in Sacramento, California.
- Sponsor
- University of California, Davis
- Study ID
- NCT06014515
- Phase
- EARLY_PHASE1
- Status
- Recruiting
Conditions
- Cardiovascular Disease
- Healthy Subjects
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- 18F-FDG — DRUGEach subject will undergo a dynamic 18F-FDG PET/CT scan (this drug is FDA approved) and a dynamic 11C-butanol PET/CT scan (this drug is under an IND) on the EXPLORER total-body PET/CT system. The two scans will be performed on the same day or within a period of up to two weeks depending on subject, imaging agent and scanner availability.
- 11C-butanol — DRUGEach subject will undergo a dynamic 18F-FDG PET/CT scan (this drug is FDA approved) and a dynamic 11C-butanol PET/CT scan (this drug is under an IND) on the EXPLORER total-body PET/CT system. The two scans will be performed on the same day or within a period of up to two weeks depending on subject, imaging agent and scanner availability.
Study Details
The overarching goal of this project is to develop and evaluate a single-tracer multiparametric positron emission tomography (PET) imaging solution for simultaneous imaging of blood flow and glucose metabolism using 18F-fluorodeoxyglucose (FDG) alone. The investigators working hypothesis is that quantitative blood flow can be extracted from dynamic 18F-FDG PET data by use of tracer kinetic modeling, in addition to glucose metabolism that 18F-FDG is conventionally used for.
Key Dates
- Start date
- Feb 14, 2024
- Status verified
- Jul 2025
- Primary completion
- Aug 31, 2028
- Completion
- Aug 31, 2033
Study Design
- Enrollment
- 60 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- BASIC_SCIENCE
Arms
- Experimental: Experimental: PET/CT scansEach subject will undergo a dynamic 18F-FDG PET/CT scan and a dynamic 11C-butanol PET/CT scan on the EXPLORER total-body PET/CT system
Primary Outcome Measure
Blood Flow [ Time Frame: during the procedure ]
Central Contacts
- Clinical Research Team916-731-9004
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| UC Davis EXPLORER Molecular Imaging Center | Sacramento | California | 95816 | Guobao Wang, PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Sacramento, CA
By research site
Related Studies
- WISE CVD - Continuation (WISE HFpEF)Recruiting · Cedars-Sinai Medical Center · Los Angeles, California
- Randomized Trial of SGLT2i in Heart Transplant RecipientsPHASE4 · Recruiting · VA Office of Research and Development · Palo Alto, California
- A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First EventPHASE3 · Recruiting · AstraZeneca · Athens, Alabama
- Effect of Proton Pump Inhibitors on Gut Microbiota Composition and Metabolites in Healthy Subjects Using CapScanPHASE1 · Not Yet Recruiting · Envivo Bio Inc · Mountain View, California